Abstract
The incidence of head and neck cancer increases every year, and represents a significant problem for Molecular Biology at the beginning of the Twenty-first Century. Despite advances in treatment, most studies still strive to deepen the understanding of the mechanisms of cancerogenesis. In order to develop more effective methods of diagnosis and therapy, it is necessary to understand the molecular basis of the neoplastic transformation process. Such findings obtained by research into Molecular Biology, Molecular Epidemiology and Genetics have brought significant progress in understanding the complex, multi- step process which takes place during tumor formation. For many years, there has been great interest in the use of complex compounds, particular complexes between heterocyclic compounds and the metals Pt (II), Pd (II), Cu (II) and Ru (III). One such compound is an azole called pyrazole; the azoles are known to have analgesic, antipyretic, anti-tumor, anti-inflammatory and anti-fungal effects. Improved synthetic and separation methods and biochemical techniques have improved the identification of compounds with biological activity. The main aim of this review is to present complexes with Pt (II), Pd (II), Cu (II) and Ru (III) ions which demonstrate antioxidant and anti-cancer properties.
Keywords: Pyrazoles, complexes of Pt(II), Cu(II), Ru(III) and Pd(II), antioxidant, anticancer properties, antioxidative barrier, chemiotherapeutics.
Mini-Reviews in Medicinal Chemistry
Title:An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy
Volume: 18 Issue: 16
Author(s): Malinowska Katarzyna, Szczepanska Anna*, Hanna Zielinska-Blizniewska and Majsterek Ireneusz
Affiliation:
- Department of Chemistry and Clinical Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz,Poland
Keywords: Pyrazoles, complexes of Pt(II), Cu(II), Ru(III) and Pd(II), antioxidant, anticancer properties, antioxidative barrier, chemiotherapeutics.
Abstract: The incidence of head and neck cancer increases every year, and represents a significant problem for Molecular Biology at the beginning of the Twenty-first Century. Despite advances in treatment, most studies still strive to deepen the understanding of the mechanisms of cancerogenesis. In order to develop more effective methods of diagnosis and therapy, it is necessary to understand the molecular basis of the neoplastic transformation process. Such findings obtained by research into Molecular Biology, Molecular Epidemiology and Genetics have brought significant progress in understanding the complex, multi- step process which takes place during tumor formation. For many years, there has been great interest in the use of complex compounds, particular complexes between heterocyclic compounds and the metals Pt (II), Pd (II), Cu (II) and Ru (III). One such compound is an azole called pyrazole; the azoles are known to have analgesic, antipyretic, anti-tumor, anti-inflammatory and anti-fungal effects. Improved synthetic and separation methods and biochemical techniques have improved the identification of compounds with biological activity. The main aim of this review is to present complexes with Pt (II), Pd (II), Cu (II) and Ru (III) ions which demonstrate antioxidant and anti-cancer properties.
Export Options
About this article
Cite this article as:
Katarzyna Malinowska, Anna Szczepanska*, Zielinska-Blizniewska Hanna and Ireneusz Majsterek, An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy, Mini-Reviews in Medicinal Chemistry 2018; 18 (16) . https://dx.doi.org/10.2174/1389557518666180423145825
DOI https://dx.doi.org/10.2174/1389557518666180423145825 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hedgehog Signaling and Urological Cancers
Current Drug Targets Adhesion Molecules in Lung Cancer: Implications in the Pathogenesis and Management
Current Pharmaceutical Design Recent Developments in Tumor Angiogenesis
Current Pharmaceutical Biotechnology The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Molecule of the Month
Current Topics in Medicinal Chemistry Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Linkage of Stress with Neuromuscular Disorders
CNS & Neurological Disorders - Drug Targets Listeria monocytogenes as a Vector for Anti-Cancer Therapies
Current Gene Therapy Polymer Nanoparticles - A Novel Strategy for Administration of Paclitaxel in Cancer Chemotherapy
Current Medicinal Chemistry Role of Invariant Natural Killer T (iNKT) Cells in Systemic Lupus Erythematosus
Current Medicinal Chemistry Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway
Anti-Cancer Agents in Medicinal Chemistry Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design Development of <sup>18</sup>F-Labeled PET Probes for Imaging Cell Proliferation
Current Topics in Medicinal Chemistry N-Succinyl Chitosan as Buccal Penetration Enhancer for Delivery of Herbal Agents in Treatment of Oral Mucositis
Current Drug Delivery Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Human Aurora / Ipl1p Related Kinases
Current Genomics Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Between Primary Tumor, Metastatic Node and Normal Tissue in Head and Neck Cancer
Current Medical Imaging Actively Targeted Nanoparticles for Drug Delivery to Tumor
Current Drug Metabolism